SEC FORM 4
$481,154.62
UNITED THERAPEUTICS Corp (UTHR)
Sale of 878 shares at $548.0121 per share.
Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S
Traded Oct 9, 2026 · Disclosed Oct 13, 2026
Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →